Literature DB >> 20411370

Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure.

Jamie L Nelsen1, Jeff Lapoint, Michael J Hodgman, Kenneth M Aldous.   

Abstract

Reports of toxicity secondary to Kratom are rare and lack of diagnostic testing in human specimens has prevented confirmatory explanation of observed clinical effects. We present a novel case of serious human toxicity following Kratom use confirmed via quantitative analysis of urine by high performance liquid chromatography coupled to electrospray tandem mass spectrometry. A 64 year-old male was witnessed to have a seizure at home following kratom consumption. Upon arrival to the emergency department (ED), the patient was unresponsive. While in the ED, the patient sustained a second seizure. He was intubated to protect his airway. The remainder of his hospital course was uneventful. A urine specimen was collected shortly after admission and sent for analysis. The mitragynine concentration in the urine was 167 ± 15 ng/ml. We report a rare case of Kratom toxicity characterized by a seizure and coma confirmed by urinary analysis of mitragynine by high performance liquid chromatography coupled to electrospray tandem mass spectrometry. The proposed mechanism for this reaction is unclear but suggested mechanisms include adenosine binding or stimulation of adrenergic and/or serotonergic receptors similar to tramadol.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411370      PMCID: PMC3550469          DOI: 10.1007/s13181-010-0079-5

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  34 in total

Review 1.  Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy?

Authors:  Jeanine Ward; Christopher Rosenbaum; Christina Hernon; Christopher R McCurdy; Edward W Boyer
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

Review 2.  Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.

Authors:  Christopher D Rosenbaum; Stephanie P Carreiro; Kavita M Babu
Journal:  J Med Toxicol       Date:  2012-03

Review 3.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

4.  Novel case of maternal and neonatal kratom dependence and withdrawal.

Authors:  Lindsay Mackay; Ronald Abrahams
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

5.  Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.

Authors:  Rhome L Hughes
Journal:  Forensic Sci Med Pathol       Date:  2018-11-29       Impact factor: 2.007

6.  Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this 'legal high' substance more dangerous than initially thought ?

Authors:  Hafez Mohammad Ammar Abdullah; Iqra Haq; Randall Lamfers
Journal:  BMJ Case Rep       Date:  2019-07-19

7.  Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa).

Authors:  Friedrich G Kapp; Hans H Maurer; Volker Auwärter; Martin Winkelmann; Maren Hermanns-Clausen
Journal:  J Med Toxicol       Date:  2011-09

8.  The inhibitory effects of mitragynine on P-glycoprotein in vitro.

Authors:  Noradliyanti Rusli; Azimah Amanah; Gurjeet Kaur; Mohd Ilham Adenan; Shaida Fariza Sulaiman; Habibah Abdul Wahab; Mei Lan Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-02       Impact factor: 3.000

9.  Posterior reversible leukoencephalopathy syndrome after kratom ingestion.

Authors:  Austin Castillo; J Drew Payne; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

10.  Lateral Flow Assessment and Unanticipated Toxicity of Kratom.

Authors:  Lauren C Smith; Lucy Lin; Candy S Hwang; Bin Zhou; Diane M Kubitz; Huiying Wang; Kim D Janda
Journal:  Chem Res Toxicol       Date:  2018-11-16       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.